YUPELRI® INHALATION SOLUTION 175MCG/3ML
Product details
Registration number: SIN16336P
Classification: Prescription Only
Active ingredients: Revefenacin
Strength: 175 mcg /3 ml
Dosage form: SOLUTION
Route: RESPIRATORY (INHALATION)
Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.
ATC code: R03BB08
HSA approval date: 28 September 2021
Manufacturer(s): The Ritedose Corporation (TRC)
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for YUPELRI® INHALATION SOLUTION 175MCG/3ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16336P
Classification: Prescription Only
What active ingredients and strength are recorded for YUPELRI® INHALATION SOLUTION 175MCG/3ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Revefenacin
Strength: 175 mcg /3 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for YUPELRI® INHALATION SOLUTION 175MCG/3ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION
Route: RESPIRATORY (INHALATION)
Who is the recorded registrant for YUPELRI® INHALATION SOLUTION 175MCG/3ML?
According to the HSA dataset updated 7 August 2026:
Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.
Which manufacturers and countries are listed for YUPELRI® INHALATION SOLUTION 175MCG/3ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): The Ritedose Corporation (TRC)
Manufacturing country/countries: UNITED STATES
Where can I look up YUPELRI® INHALATION SOLUTION 175MCG/3ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16336P or the exact product name YUPELRI® INHALATION SOLUTION 175MCG/3ML. The general register link does not preselect this product.
What are the source dates for this YUPELRI® INHALATION SOLUTION 175MCG/3ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this YUPELRI® INHALATION SOLUTION 175MCG/3ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16336P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)